Institutes for Systems Genetics, West China Hospital
Copyright @ 2022 ISG. All Rights Reserved.
ncRNA
hsa-miR-139-5p
Specific or universal ncRNAs
Universal ncRNAs
Class
MicroRNA
Biomarker
Yes
Biomarker application
Prognosis
Upstream regulatory factor
Not available
Downstream target
IGF1R/AXL
Differential expression in
recurrence vs. nonrecurrence
Not available
Cancer name
Prostate Cancer
Alias
Cancer site
Prostate
Recurrence type
Recurrence
Overall survival rate of patients with
high ncRNA expression
Up
ncRNA differential expression in
cancer
patients vs. health people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
Recurrence patients
Not available
Recurrence patients male:female
Not available
Recurrence patients age range
Not available
Recurrence mean age
Not available
Sites of recurrence
Not available
Patients without recurrence
Not available
Patients without recurrence male:female
Patients without recurrence age range
Not available
Patients without recurrence mean age
Not available
PMID
Description
MiR-139 expression was associated with prognosis: the cumulative incidence of biochemical recurrence and metastasis were significantly lower among patients with high miR-139 expression.
Tissue resource
prostate cancer cell lines PC3
prostate cancer cell lines Du145
HEK293T cell lines
Experiment
qRT-PCR,Western blot,Dual-Luciferase reporter assay
Institute
Country
Continent
Institutes for Systems Genetics, West China Hospital
Copyright @ 2022 ISG. All Rights Reserved.